GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurizon Therapeutics Ltd (FRA:ECQ0) » Definitions » PB Ratio

Neurizon Therapeutics (FRA:ECQ0) PB Ratio : 4.53 (As of Mar. 29, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Neurizon Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-29), Neurizon Therapeutics's share price is €0.068. Neurizon Therapeutics's Book Value per Share for the quarter that ended in Dec. 2024 was €0.02. Hence, Neurizon Therapeutics's PB Ratio of today is 4.53.

The historical rank and industry rank for Neurizon Therapeutics's PB Ratio or its related term are showing as below:

FRA:ECQ0' s PB Ratio Range Over the Past 10 Years
Min: 0.78   Med: 3.11   Max: 34.55
Current: 6.26

During the past 13 years, Neurizon Therapeutics's highest PB Ratio was 34.55. The lowest was 0.78. And the median was 3.11.

FRA:ECQ0's PB Ratio is ranked worse than
72.78% of 1282 companies
in the Biotechnology industry
Industry Median: 2.385 vs FRA:ECQ0: 6.26

During the past 12 months, Neurizon Therapeutics's average Book Value Per Share Growth Rate was 20.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -6.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -10.10% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -14.60% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Neurizon Therapeutics was 86.60% per year. The lowest was -75.30% per year. And the median was -18.00% per year.

Back to Basics: PB Ratio


Neurizon Therapeutics PB Ratio Historical Data

The historical data trend for Neurizon Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurizon Therapeutics PB Ratio Chart

Neurizon Therapeutics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.18 2.81 2.66 5.14 6.25

Neurizon Therapeutics Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.13 5.14 5.13 6.25 6.10

Competitive Comparison of Neurizon Therapeutics's PB Ratio

For the Biotechnology subindustry, Neurizon Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurizon Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurizon Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Neurizon Therapeutics's PB Ratio falls into.


;
;

Neurizon Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Neurizon Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=0.068/0.015
=4.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Neurizon Therapeutics  (FRA:ECQ0) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Neurizon Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Neurizon Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurizon Therapeutics Business Description

Traded in Other Exchanges
Address
96-100 Albert Road, Level 4, South Melbourne, Melbourne, VIC, AUS, 3205
Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

Neurizon Therapeutics Headlines

No Headlines